Drug Trial Radar · NCT05512806
A Bioavailability and Food Effect Study of AZD5462 in Healthy Volunteers
Last checked: Nov 19, 2026Latest source record: Nov 9, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
16
Actual
Start
Aug 24, 2022
Primary completion
Nov 7, 2022
Study completion Nov 7, 2022
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- Collaborators
- Parexel
- First posted
- Aug 23, 2022
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 55 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study will assess the pharmacokinetics of AZD5462 film-coated tablet formulation in healthy participants.
Conditions
- Healthy Participants
Interventions
AZD5462Drug
Participants will receive AZD5462 orally.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Area under plasma concentration time curve from zero to infinity (AUCinf)Time frame: Day 1 to Day 17
- Area under the plasma concentration-curve from time zero to last quantifiable concentration (AUClast)Time frame: Day 1 to Day 17
- Maximum observed plasma (peak) drug concentration [Cmax]Time frame: Day 1 to Day 17
- Area under plasma concentration time curve from zero to infinity (AUCinf)Time frame: Day 1 to Day 17
- Area under the plasma concentration-curve from time zero to last quantifiable concentration (AUClast)Time frame: Day 1 to Day 17
- Maximum observed plasma (peak) drug concentration [Cmax]Time frame: Day 1 to Day 17
- Area under plasma concentration time curve from zero to infinity (AUCinf)Time frame: Day 1 to Day 17
- Area under the plasma concentration-curve from time zero to last quantifiable concentration (AUClast)Time frame: Day 1 to Day 17
- Maximum observed plasma (peak) drug concentration [Cmax]Time frame: Day 1 to Day 17
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Research Site
Brooklyn, Maryland
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.